# FutureFuel Corp.: financial statements, quarterly

FF · NYSE · CIK 1337298 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ff.md) · [Financials](/companies/ff/financials.md) · [Filings](/companies/ff/filings.md) · [Insiders](/companies/ff/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ff/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [117](/filings/0001437749-24-034210.md) | [92.0](/filings/0001437749-24-015973.md) | [58.3](/filings/0001437749-25-016125.md) | [72.4](/filings/0001437749-25-025926.md) | [51.1](/filings/0001437749-25-034102.md) | [61.5 d](/filings/0001437749-26-008411.md) | [17.5](/filings/0001437749-26-016116.md) | [35.7](/filings/0001437749-26-026784.md) | [22.7](/filings/0001437749-25-034102.md) | [19.8 d](/filings/0001437749-26-008411.md) | [32.0](/filings/0001437749-26-016116.md) | [78.7](/filings/0001437749-26-026784.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [32.2](/filings/0001437749-26-016116.md) | [47.4](/filings/0001437749-26-026784.md) | not reported | not reported | not reported | not reported |
| Gross profit | $m | [3.9](/filings/0001437749-24-034210.md) | [24.1](/filings/0001437749-24-015973.md) | [5.0](/filings/0001437749-25-016125.md) | [8.7](/filings/0001437749-25-025926.md) | [0.4](/filings/0001437749-25-034102.md) | [5.6 d](/filings/0001437749-26-008411.md) | [(15.2)](/filings/0001437749-26-016116.md) | [(12.4)](/filings/0001437749-26-026784.md) | [(6.8)](/filings/0001437749-25-034102.md) | [(9.3) d](/filings/0001437749-26-008411.md) | [(15.9)](/filings/0001437749-26-016116.md) | [15.0](/filings/0001437749-26-026784.md) |
| Research and development | $m | [1.2](/filings/0001437749-24-034210.md) | [1.2 d](/filings/0001437749-26-008411.md) | [0.9](/filings/0001437749-25-016125.md) | [0.9](/filings/0001437749-25-025926.md) | [1.0](/filings/0001437749-25-034102.md) | [1.2 d](/filings/0001437749-26-008411.md) | [1.4](/filings/0001437749-26-016116.md) | [0.9](/filings/0001437749-26-026784.md) | [0.9](/filings/0001437749-25-034102.md) | [0.7 d](/filings/0001437749-26-008411.md) | [0.8](/filings/0001437749-26-016116.md) | [0.7](/filings/0001437749-26-026784.md) |
| Selling, general and administrative | $m | not reported | not reported | [1.9](/filings/0001437749-25-016125.md) | [2.3](/filings/0001437749-25-025926.md) | [2.3](/filings/0001437749-25-034102.md) | [2.8 d](/filings/0001437749-26-008411.md) | [2.9](/filings/0001437749-26-016116.md) | [2.2](/filings/0001437749-26-026784.md) | [2.0](/filings/0001437749-25-034102.md) | [2.5 d](/filings/0001437749-26-008411.md) | [4.1](/filings/0001437749-26-016116.md) | [3.1](/filings/0001437749-26-026784.md) |
| Operating income | $m | [0.3](/filings/0001437749-24-034210.md) | [20.4 d](/filings/0001437749-26-008411.md) | [2.2](/filings/0001437749-25-016125.md) | [5.5](/filings/0001437749-25-025926.md) | [(2.9)](/filings/0001437749-25-034102.md) | [1.6 d](/filings/0001437749-26-008411.md) | [(19.5)](/filings/0001437749-26-016116.md) | [(15.6)](/filings/0001437749-26-026784.md) | [(9.7)](/filings/0001437749-25-034102.md) | [(12.5) d](/filings/0001437749-26-008411.md) | [(20.8)](/filings/0001437749-26-016116.md) | [11.3](/filings/0001437749-26-026784.md) |
| Interest expense | $m | [0.0](/filings/0001437749-24-015978.md) | [0.0 d](/filings/0001437749-24-015973.md) | [0.0](/filings/0001437749-24-016012.md) | [0.0](/filings/0001437749-25-025926.md) | [0.0](/filings/0001437749-25-034102.md) | [0.0 d](/filings/0001437749-26-008411.md) | [0.0](/filings/0001437749-26-016116.md) | [0.0](/filings/0001437749-26-026784.md) | [0.1](/filings/0001437749-25-034102.md) | [(0.0) d](/filings/0001437749-26-008411.md) | [0.0](/filings/0001437749-26-016116.md) | [0.0](/filings/0001437749-26-026784.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-034210.md) | [(0.0) d](/filings/0001437749-26-008411.md) | [0.6](/filings/0001437749-25-016125.md) | [0.0](/filings/0001437749-25-025926.md) | [(0.0)](/filings/0001437749-25-034102.md) | [0.2 d](/filings/0001437749-26-008411.md) | [(0.2)](/filings/0001437749-26-016116.md) | [0.2](/filings/0001437749-26-026784.md) | [(0.0)](/filings/0001437749-25-034102.md) | [0.2 d](/filings/0001437749-26-008411.md) | [0.0](/filings/0001437749-26-016116.md) | [0.1](/filings/0001437749-26-026784.md) |
| Net income | $m | [2.8](/filings/0001437749-24-034210.md) | [23.4](/filings/0001437749-24-015973.md) | [4.3](/filings/0001437749-25-034102.md) | [9.6](/filings/0001437749-25-034102.md) | [(1.2)](/filings/0001437749-25-034102.md) | [2.8 d](/filings/0001437749-26-008411.md) | [(18.1)](/filings/0001437749-26-026784.md) | [(14.2)](/filings/0001437749-26-026784.md) | [(9.3)](/filings/0001437749-25-034102.md) | [(12.0) d](/filings/0001437749-26-008411.md) | [(20.6)](/filings/0001437749-26-026784.md) | [11.4](/filings/0001437749-26-026784.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001437749-24-034210.md) | [0.53](/filings/0001437749-24-015973.md) | [0.10](/filings/0001437749-25-016125.md) | [0.22](/filings/0001437749-25-025926.md) | [(0.03)](/filings/0001437749-25-034102.md) | not reported | [(0.41)](/filings/0001437749-26-016116.md) | [(0.32)](/filings/0001437749-26-026784.md) | [(0.21)](/filings/0001437749-25-034102.md) | not reported | [(0.47)](/filings/0001437749-26-016116.md) | [0.25](/filings/0001437749-26-026784.md) |
| Basic EPS | $ per share | [0.06](/filings/0001437749-24-034210.md) | [0.53](/filings/0001437749-24-015973.md) | [0.10](/filings/0001437749-25-016125.md) | [0.22](/filings/0001437749-25-025926.md) | [(0.03)](/filings/0001437749-25-034102.md) | not reported | [(0.41)](/filings/0001437749-26-016116.md) | [(0.32)](/filings/0001437749-26-026784.md) | [(0.21)](/filings/0001437749-25-034102.md) | not reported | [(0.47)](/filings/0001437749-26-016116.md) | [0.25](/filings/0001437749-26-026784.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [206](/filings/0001437749-24-015978.md) | [219](/filings/0001437749-25-010192.md) | [201](/filings/0001437749-24-016012.md) | [115](/filings/0001437749-24-025859.md) | [133](/filings/0001437749-24-034210.md) | [110](/filings/0001437749-26-008411.md) | [97.1](/filings/0001437749-25-016125.md) | [95.2](/filings/0001437749-25-025926.md) | [85.6](/filings/0001437749-25-034102.md) | [51.3](/filings/0001437749-26-026784.md) | [22.4](/filings/0001437749-26-016116.md) | [34.4](/filings/0001437749-26-026784.md) |
| Current assets | $m | [267](/filings/0001437749-24-015978.md) | [291](/filings/0001437749-25-010192.md) | [289](/filings/0001437749-24-016012.md) | [184](/filings/0001437749-24-025859.md) | [176](/filings/0001437749-24-034210.md) | [165](/filings/0001437749-26-008411.md) | [149](/filings/0001437749-26-016116.md) | [131](/filings/0001437749-26-026784.md) | [113](/filings/0001437749-25-034102.md) | [109](/filings/0001437749-26-026784.md) | [84.1](/filings/0001437749-26-016116.md) | [116](/filings/0001437749-26-026784.md) |
| Total assets | $m | [346](/filings/0001437749-24-015978.md) | [367](/filings/0001437749-25-010192.md) | [365](/filings/0001437749-24-016012.md) | [261](/filings/0001437749-24-025859.md) | [256](/filings/0001437749-24-034210.md) | [248](/filings/0001437749-26-008411.md) | [233](/filings/0001437749-26-016116.md) | [220](/filings/0001437749-26-026784.md) | [203](/filings/0001437749-25-034102.md) | [200](/filings/0001437749-26-026784.md) | [179](/filings/0001437749-26-016116.md) | [215](/filings/0001437749-26-026784.md) |
| Current liabilities | $m | [32.1](/filings/0001437749-24-015978.md) | [41.3](/filings/0001437749-25-010192.md) | [145](/filings/0001437749-24-016012.md) | [33.1](/filings/0001437749-24-025859.md) | [29.7](/filings/0001437749-24-034210.md) | [33.3](/filings/0001437749-26-008411.md) | [30.5](/filings/0001437749-25-016125.md) | [30.9](/filings/0001437749-25-025926.md) | [25.3](/filings/0001437749-25-034102.md) | [17.7](/filings/0001437749-26-026784.md) | [17.6](/filings/0001437749-26-016116.md) | [28.6](/filings/0001437749-26-026784.md) |
| Total liabilities | $m | [48.8](/filings/0001437749-24-015978.md) | [57.2](/filings/0001437749-25-010192.md) | [161](/filings/0001437749-24-016012.md) | [46.8](/filings/0001437749-24-025859.md) | [43.2](/filings/0001437749-24-034210.md) | [41.9](/filings/0001437749-26-008411.md) | [39.2](/filings/0001437749-26-016116.md) | [40.1](/filings/0001437749-26-026784.md) | [34.4](/filings/0001437749-25-034102.md) | [37.7](/filings/0001437749-26-026784.md) | [37.1](/filings/0001437749-26-016116.md) | [62.0](/filings/0001437749-26-026784.md) |
| Shareholders' equity | $m | [297](/filings/0001437749-24-034210.md) | [310](/filings/0001437749-26-008411.md) | [205](/filings/0001437749-25-034102.md) | [214](/filings/0001437749-25-034102.md) | [213](/filings/0001437749-25-034102.md) | [206](/filings/0001437749-26-026784.md) | [194](/filings/0001437749-26-026784.md) | [180](/filings/0001437749-26-026784.md) | [169](/filings/0001437749-25-034102.md) | [163](/filings/0001437749-26-026784.md) | [142](/filings/0001437749-26-026784.md) | [153](/filings/0001437749-26-026784.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.1 d](/filings/0001437749-24-034210.md) | [12.8 d](/filings/0001437749-26-008411.md) | [(12.2)](/filings/0001437749-25-016125.md) | [27.8 d](/filings/0001437749-25-025926.md) | [25.8 d](/filings/0001437749-25-034102.md) | [(16.6) d](/filings/0001437749-26-008411.md) | [(5.4)](/filings/0001437749-26-016116.md) | [5.2 d](/filings/0001437749-26-026784.md) | [(1.1) d](/filings/0001437749-25-034102.md) | [(27.4) d](/filings/0001437749-26-008411.md) | [(20.0)](/filings/0001437749-26-016116.md) | [18.8 d](/filings/0001437749-26-026784.md) |
| Capital expenditure | $m | [1.1 d](/filings/0001437749-24-034210.md) | [1.0 d](/filings/0001437749-26-008411.md) | [2.3](/filings/0001437749-25-016125.md) | [3.0 d](/filings/0001437749-25-025926.md) | [5.3 d](/filings/0001437749-25-034102.md) | [4.1 d](/filings/0001437749-26-008411.md) | [4.0](/filings/0001437749-26-016116.md) | [5.5 d](/filings/0001437749-26-026784.md) | [5.3 d](/filings/0001437749-25-034102.md) | [2.4 d](/filings/0001437749-26-008411.md) | [5.4](/filings/0001437749-26-016116.md) | [8.0 d](/filings/0001437749-26-026784.md) |
| Dividends paid | $m | [2.6 d](/filings/0001437749-24-034210.md) | [2.6 d](/filings/0001437749-26-008411.md) | [2.6](/filings/0001437749-25-016125.md) | [112 d](/filings/0001437749-25-025926.md) | [2.6 d](/filings/0001437749-25-034102.md) | [2.6 d](/filings/0001437749-26-008411.md) | [2.6](/filings/0001437749-26-016116.md) | [2.6 d](/filings/0001437749-26-026784.md) | [2.6 d](/filings/0001437749-25-034102.md) | [2.6 d](/filings/0001437749-26-008411.md) | [2.6](/filings/0001437749-26-016116.md) | [0.4 d](/filings/0001437749-26-026784.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [43.8](/filings/0001437749-24-015978.md) | [43.8](/filings/0001437749-24-016012.md) | [43.8](/filings/0001437749-24-025859.md) | [43.8](/filings/0001437749-24-034210.md) | [43.8](/filings/0001437749-25-016125.md) | [43.8](/filings/0001437749-25-025926.md) | [43.8](/filings/0001437749-25-034102.md) | [43.8](/filings/0001437749-26-016116.md) | [43.8](/filings/0001437749-26-026784.md) | [43.8](/filings/0001437749-25-034102.md) | [44.0](/filings/0001437749-26-016116.md) | [44.0](/filings/0001437749-26-026784.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 43,863,318 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001437749-26-026784.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.